BIOMEDSOFT COMPUTATIONAL SOFTWARE SUITES

BiomedSoft LLC specializes in transforming validated legacy desktop biostatistical algorithms into secure, high-performance, and cloud-native Software-as-a-Service (SaaS) architectures. Our core proprietary computing engines are currently undergoing advanced cloud migration to ensure seamless API integration capabilities for decentralized trials.

SCEW (survival curves in Excel worksheet)

Current Status: Phase I cloud architecture migration underway (targeting SaaS deployment)

Core Logic: Automates deterministic, binary break-up algorithms to generate precise Kaplan-Meier survival curves and non-parametric log-rank comparative statistics.

Impact History: Evaluated and utilized by researchers at elite global hubs, including WHO, Yale, Johns Hopkins, Duke, McGill University, University of Washington, University of British Columbia, etc.

Scientific Anchor: Published in Computer Methods and Programs in Biomedicine (PMID: 16413628).

CalcNTCP (Normal Tissue Complication Probability Modeler)

Current Status: Regulatory compliance and interface alignment phase

Core Logic: Executes fast and accurate biological evaluations of normal tissue complication probabilities using the Lyman-Kutcher-Burman (LKB) model.

Impact History: Evaluated and utilized by oncology researchers at elite global hubs, including Massachusetts General Hospital, Harvard Medical School, Wayne State University, Tata Memorial Center.

Scientific Anchor: Published in the International Journal of Radiation Biology (PMID: 17729166).

CalcFisher (Statistical Analysis Automation Module)

Current Status: Backend API optimization and vectorization testing

Core Logic: Computes hyper-precise, exact non-parametric p-value distributions for significance tracking for multi-cohort clinical groupings.

Impact History: Evaluated and utilized by oncology researchers at elite global hubs, including Emory University, Tomsk State University, Swinburne University, National University of Singapore.

Scientific Anchor: Published in the Journal of Statistical Software (DOI: 10.18637/jss.v008.i21)

CalcDose (drug dosage interspecies conversion)

Current Status: API microservice configuration and unit testing

Core Logic: Calculates precise, inter-species drug dosage conversions based on the Metabolically Active Mass (MAM) of animals rather than basic body weight alone. Prevents calculation errors in preclinical translational research models.

Impact History: Evaluated and utilized by researchers at elite hubs, including All India Institute of Medical Sciences.

Scientific Anchor: Published in Drug and Chemical Toxicology (PMID: 12643040).